Table 1.
Patient and disease characteristics
| Gender | |
| Female:Male | 13:13 |
| Age | |
| Median (min, max) | 63.5 (46, 84) |
| ECOG | |
| 0 | 17 |
| 1 | 8 |
| 2 | 1 |
| Cancer histology | |
| NSCLC | 22 19 Adenocarcinoma 2 Adenosquamous 1 squamous |
| RCC (clear-cell) | 4 |
| Tumor PD-L1 status | |
| Unknown | 5 (4 RCC, 1 insufficient material) |
| <1% | 5 |
| 1–49% | 4 |
| ≥50% | 12 |
| Prior systemic therapy | |
| 0 Line | 15 |
| 1 Line | 4 |
| 2–5 Lines | 7 |
| Prior brain metastasis treatments | |
| Yes | 9 |
| SRS treated lesions | |
| Median (min, max) | 3 (1, 9) |
| Total SRS volume (cc) | |
| Median (min, max) | 0.78 (0.078, 6.4) |
| Presence of extracranial disease | |
| Yes | 22 |
| Follow-up | |
| Median months (min, max) | 15.0 (0.43, 25.9) |
NSCLC, non-small cell lung carcinoma; RCC, renal cell carcinoma.